For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
CorMedix Inc (NASDAQ: CRMD) closed the day trading at $7.34 down -31.85% from the previous closing price of $10.77. In other words, the price has decreased by -$31.85 from its previous closing price. On the day, 18.75 million shares were traded. CRMD stock price reached its highest trading level at $9.25 during the session, while it also had its lowest trading level at $6.9201.
Ratios:
For a better understanding of CRMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 07, 2025, initiated with a Outperform rating and assigned the stock a target price of $18.
On January 13, 2025, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $15.
On August 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $13.Rodman & Renshaw initiated its Buy rating on August 26, 2024, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 653493440 and an Enterprise Value of 608020416. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.33 while its Price-to-Book (P/B) ratio in mrq is 7.24. Its current Enterprise Value per Revenue stands at 49.585 whereas that against EBITDA is -11.977.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.37, which has changed by 0.76442313 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $3.61. The 50-Day Moving Average of the stock is -31.74%, while the 200-Day Moving Average is calculated to be -11.23%.
Shares Statistics:
Over the past 3-months, CRMD traded about 1.01M shares per day on average, while over the past 10 days, CRMD traded about 2588340 shares per day. A total of 60.68M shares are outstanding, with a floating share count of 59.25M. Insiders hold about 2.35% of the company’s shares, while institutions hold 37.73% stake in the company. Shares short for CRMD as of 1740700800 were 7876541 with a Short Ratio of 7.76, compared to 1738281600 on 7177892. Therefore, it implies a Short% of Shares Outstanding of 7876541 and a Short% of Float of 12.989999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
